Scott M. Plesha

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Daniel Island, SC
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Francis Knuettel II, by power of attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Scott M. Plesha

Form 4 holding CEO and President, Director

Channel Therapeutics Corp

Security class
Restricted Stock Units
Shares / value
83,678
Estimated value
Report date
02 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and Chief Commercial Officer

BIODELIVERY SCIENCES INTERNATIONAL INC

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
22 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and Chief Commercial Officer

BIODELIVERY SCIENCES INTERNATIONAL INC

Security class
Stock Options (right to buy)
Shares / value
0
Estimated value
Report date
22 Mar 2022
Price
$2.93
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Scott M. Plesha

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .